Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.9K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.1K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.8K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

1.9K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phlegmasia Cerulea Dolens With Compartment Syndrome.

WMJ : official publication of the State Medical Society of Wisconsin·2026
Same author

Impact of Early Initiation of Automated Insulin Delivery on Glycemia Two Years from Type 1 Diabetes Diagnosis.

Hormone research in paediatrics·2026
Same author

Prediabetes in children and adolescents in Israel: a large-scale retrospective cohort study.

European journal of pediatrics·2026
Same author

Divalent HIV-1 gp120 Immunogen Exhibits Selective Avidity for Broadly Neutralizing Antibody VRC01 Precursors.

Vaccines·2026
Same author

ASH's commitment to SCD: building on 10 years of progress.

Blood advances·2025
Same author

Value-Based Payments Associated With Improved Quality Of Care At Federally Qualified Health Centers, 2014-23.

Health affairs (Project Hope)·2025

Related Experiment Video

Updated: Mar 1, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.6K

Effectiveness of Evidence-Based Asthma Interventions.

Suzanne Kennedy1, Ryan Bailey2, Katy Jaffee2

  • 1Rho, Chapel Hill, North Carolina; suzanne_kennedy@unc.edu.

Pediatrics
|June 1, 2017
PubMed
Summary

Community health centers successfully adapted asthma interventions for high-risk children, significantly reducing symptom days. This bridges the gap between clinical trial efficacy and real-world effectiveness in underserved populations.

More Related Videos

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.8K
Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
04:24

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

1.3K

Related Experiment Videos

Last Updated: Mar 1, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.6K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.8K
Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
04:24

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

1.3K

Area of Science:

  • Community Health
  • Pediatric Asthma Management
  • Clinical Trial Adaptation

Background:

  • Bridging the efficacy-effectiveness gap in clinical research is crucial.
  • The Community Healthcare for Asthma Management and Prevention of Symptoms (CHAMPS) study adapted a proven randomized controlled trial.
  • The goal was to implement evidence-based asthma interventions in community health centers.

Purpose of the Study:

  • To evaluate the effectiveness of adapted evidence-based asthma interventions in community health centers.
  • To reduce asthma-related morbidity in high-risk, low-income pediatric populations.
  • To assess the feasibility of implementing such interventions in primary care settings.

Main Methods:

  • Enrolled 590 children (aged 5-12) with moderate-to-severe asthma from intervention and control sites in underserved communities.
  • Provided tailored asthma interventions over 1 year, including allergen sensitivity testing and home environmental assessments.
  • Monitored study visits via electronic data capture and evaluated symptoms and healthcare utilization at baseline, 6, and 12 months.

Main Results:

  • A total of 590 children were enrolled (314 intervention, 276 control).
  • Intervention participants showed a significantly greater reduction in asthma symptom days compared to controls (-3.27 vs -2.28).
  • Study activity completion was 70%, demonstrating feasibility in this setting.

Conclusions:

  • Evidence-based asthma interventions can be effectively adapted for primary care settings serving impoverished, high-risk populations.
  • These adapted interventions successfully reduced asthma morbidity in high-need children.
  • The CHAMPS study demonstrates a viable model for improving pediatric asthma care in community health centers.